CORC

浏览/检索结果: 共149条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
ET White Paper: To Find the First Earth 2.0 预印本
2022
作者:  Ge, Jian;  Zhang, Hui;  Zang, Weicheng;  Deng, Hongping;  Mao, Shude
收藏  |  浏览/下载:40/0  |  提交时间:2022/07/29
A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans 期刊论文
MICROBIOLOGY SPECTRUM, 2022, 卷号: 10
作者:  Zhang, Yang;  Zhou, Liyan;  Liu, Yan;  Zhao, Xi;  Lian, Xianqiang
收藏  |  浏览/下载:72/0  |  提交时间:2022/05/16
微生物组测序与分析专家共识 期刊论文
生物工程学报, 2020, 卷号: 36, 期号: 12, 页码: 2516-2524
作者:  段云峰;  王升跃;  陈禹保;  杨瑞馥;  李后开
收藏  |  浏览/下载:62/0  |  提交时间:2021/07/16
Unconventional crystal-field splitting in noncentrosymmetric BaTiO3 thin films 期刊论文
PHYSICAL REVIEW MATERIALS, 2020, 卷号: 4, 期号: 2
作者:  Song, Yang;  Liu, Xiaoran;  Wen, Fangdi;  Kareev, M.;  Zhang, Ruyi
收藏  |  浏览/下载:16/0  |  提交时间:2020/12/16
Metallic interfaces in a CaTiO3/LaTiO3 superlattice 期刊论文
PHYSICAL REVIEW MATERIALS, 2020, 卷号: 4, 期号: 10
作者:  Xiao, Shaozhu;  Wen, Fangdi;  Liu, Xiaoran;  Kareev, M.;  Zhang, Ruyi
收藏  |  浏览/下载:14/0  |  提交时间:2020/12/16
Tunable superconductivity of epitaxial TiN films through oxygen doping 期刊论文
AIP ADVANCES, 2020, 卷号: 10, 期号: 5
作者:  Peng, Shaoqin;  Zhang, Ruyi;  Song, Yang;  Pei, Yujuan;  Bi, Jiachang
收藏  |  浏览/下载:51/0  |  提交时间:2020/12/16
PI3K/Akt信号通路在心脏震波治疗心力衰竭大鼠模型中的作用 期刊论文
中华心血管病杂志, 2019, 卷号: 47, 期号: 6
作者:  尚雷雷;  苏振;  马雪娟;  王雁琼;  王钰
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/04
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载:61/0  |  提交时间:2019/12/05
Association of HLA-C*03:02 with methimazole-induced liver injury in Graves' disease patients 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 117
作者:  Tang, Zhijia;  Cai, Weimin;  Xian, Xiaoqiang;  Yang, Jialin;  Li, Xuesong
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:48/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace